Skip to search.
 TSX Up 0.58% TSX Ventures Up 0.01%

Neuralstem, Inc. (CUR)

-NYSE MKT
1.95 Up 0.08(4.28%) 4:00PM EDT
Add to Portfolio
Prev Close:1.87
Open:1.87
Bid:1.95 x 6400
Ask:1.96 x 5800
1y Target Est:4.75
Beta:3.36
Earnings Date:Aug 6 - Aug 10 (Est.)
Day's Range:1.85 - 1.98
52wk Range:1.46 - 4.11
Volume:257,728
Avg Vol (3m):744,868
Market Cap:176.16M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CURUp 4.28%176.16M
GERNDown 5.68%656.07M
STEMDown 2.66%56.12M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9,607.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.26
Quarterly EPS Est (Jun-15) :-0.06
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of regenerative medicine treatments based on its human neuronal stem cells and small molecule compounds. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback